Science & Enterprise subscription

Follow us on Twitter

  • The World Solved the Ozone Problem. It Can Solve Climate Change. https://t.co/BVlMgafyiM
    about 18 hours ago
  • A solid majority of Americans now says that climate change affects their communities, a finding that could affect f… https://t.co/FeSjrqpv7t
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Most in US Say Climate Change Affects Them https://t.co/5N2p07v38r #Science #Business
    about 2 days ago
  • Many thanks @deansguide for the shout-out and all of your good work for lung health. I just report on stuff. Enjoy… https://t.co/nrNcveHCJM
    about 2 days ago
  • A company developing 3-D printed outer ear tissue received a rare pediatric disease designation on its treatment de… https://t.co/Iya45fwEl2
    about 2 days ago

Please share Science & Enterprise

Early Results Show Anti-Depressive Drug Effects

Man with depression

Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder. . . . → Read More: Early Results Show Anti-Depressive Drug Effects

Q3 Venture Investing Falls, Biotech Remains Hot

Venture capital investments fell in the third quarter of 2019, both in dollar volumes and number of deals, with declines occurring in the U.S. and worldwide. . . . → Read More: Q3 Venture Investing Falls, Biotech Remains Hot

Nanoparticles Designed to Cross Blood-Brain Barrier

Neurons

Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain. . . . → Read More: Nanoparticles Designed to Cross Blood-Brain Barrier

Companies Developing Hemophilia Gene Editing Therapy

Mountain bluebird

A partnership between drug maker Novo Nordisk and biotechnology company bluebird bio is designing a treatment for hemophilia with gene-editing proteins. . . . → Read More: Companies Developing Hemophilia Gene Editing Therapy

Merck Gaining Gut Microbe Technology for Vaccines

Microbiome graphic

Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines

Peanut Allergy Patch Under FDA Review

Peanutes in shells

A device to build a tolerance of peanuts in children with a peanut allergy, worn like a patch on the skin, is under review by the Food and Drug Administration. . . . → Read More: Peanut Allergy Patch Under FDA Review

Dementia Drug Candidate in Preclinical Tests

Linda Van Eldik

A study is underway of a new treatment approach for dementia that targets inflammation and microscopic bleeding in the brain that can accompany Alzheimer’s disease. . . . → Read More: Dementia Drug Candidate in Preclinical Tests

Small Biz Grant Funds Prenatal Genetic Test

Pregnant woman

A small business set-aside grant is funding early development of a non-invasive prenatal test that simplifies detection of genetic abnormalities in a fetus. . . . → Read More: Small Biz Grant Funds Prenatal Genetic Test

Nanotech Crispr Delivery in Development

Editing a DNA strand

Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment. . . . → Read More: Nanotech Crispr Delivery in Development

Novartis, Microsoft Partner on A.I.

Artificial intelligence graphic

Drug maker Novartis is collaborating with Microsoft to extend the company’s adoption of artificial intelligence into many of its corporate functions. . . . → Read More: Novartis, Microsoft Partner on A.I.